NEPH Stock NEPH is expected to report earnings to rise+33% to -4 cents per share on May 27

A.I.dvisor
at Tickeron.com
05/26/24
Loading...
NEPH - Nephros
Nephros Earnings Graph
Q1'24
Est.
$-0.04
Q4'23
Missed
by $0.03
Q3'23
Beat
by $0.05
Q2'23
Beat
by $0.02
Q1'23
Beat
by $0.05
The last earnings report on December 31 showed earnings per share of -6 cents, missing the estimate of -3 cents. P/B Ratio (2.775) is normal, around the industry mean (22.495). P/E Ratio (0.000) is within average values for comparable stocks, (82.123). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.605) is also within normal values, averaging (51.087). With 9.86K shares outstanding, the current market capitalization sits at 23.09M.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
380 Lackawanna Place
Phone
+1 201 343-5202
Employees
31
Web
https://www.nephros.com